| Trial ID: | L0653 |
| Source ID: | IRCT201204049376N1
|
| Associated Drug: |
Probiotic
|
| Title: |
Effects of probiotic and metformin on nonalcolic steatohepatitis: a double blind randomized clinical trial.
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic steatohepatitis. <br>Inflammatory liver disease, unspecified Hepatitis NOS;Inflammatory liver disease, unspecified Hepatitis NOS
|
| Interventions: |
Intervention 1: Control group: treated with Metformin 500 mg two tablets per day plus two placebo tablet two tablets per day for six month. Intervention 2: Protexin two tablets per day plus Metformin 500 mg two tablets per day for six month.;Behavior;Trea
|
| Outcome Measures: |
Alanine transaminase (ALT). Timepoint: Before and after treatment. Method of measurement: Blood test.;Aspartate aminotransferse (AST). Timepoint: before and after treatment. Method of measurement: blood test AST.;Ultrasound Grade of NASH. Timepoint: before and after treatment. Method of measurement: ultrasound.Fasting blood suger (FBS). Timepoint: before and after treatment. Method of measurement: blood test.;Chlosterol. Timepoint: befoer and after treatment. Method of measurement: blood test.;Triglyceride. Timepoint: before and after treatment. Method of measurement: blood test.;Body mass index (BMI). Timepoint: before and after treatment. Method of measurement: measure weight and height.
|
| Sponsor/Collaborators: |
Isfahan University of Medical Sciences
|
| Gender: |
All
|
| Age: |
18 years75 years
|
| Phases: |
Not applicable
|
| Enrollment: |
63
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
|
| Start Date: |
05/07/2012
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2018
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/9912
|
